Skip to main content
. 2012 Mar 1;16(5):413–427. doi: 10.1089/ars.2011.3982

FIG. 9.

FIG. 9.

A schematic diagram showing the mechanisms by which Zyflamend sensitizes cancer cells to TRAIL-induced apoptosis. (To see this illustration in color the reader is referred to the web version of this article at www.liebertonline.com/ars).